Study details
Enrolling now
Neuromodulation and Cognitive Training for Substance Use Disorders
University of Minnesota
NCT IDNCT04426214ClinicalTrials.gov data as of Apr 2026
Target enrollment
80
Study length
about 5.1 years
Ages
18–65
Locations
1 site in MN
About this study
This trial is testing a new intervention, namely tDCS-Augmented Cognitive Training, to engage brain biomarkers of relapse vulnerability. The goal is to improve cognition and treatment outcomes in people with alcohol or stimulant use disorders.
Based on ClinicalTrials.gov records.
What participants do
- 1.Participate in Cognitive Training
- 2.Use tDCS
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Devices
therapeutic
Body systems
Psychiatry / Mental Health